Novartis Debuts Rapidly Manufactured Autologous CAR-Ts

 
• By Alaric DeArment
  
3d illustration of T cells or cancer cells
Novartis unveiled early data on its two next-generation CAR-Ts, YTB323 and PHE885 • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Immuno-oncology

More from Anticancer